Monograph
B02AB01 - Aprotinin |
Not porphyrinogenic |
NP |
Rationale
Polypeptide. No CYP-interactions.
Chemical description
Peptide proteinase inhibitor (e.g. plasmin).Used during surgery to reduce perioerative bleeding and need for blood transfusion. Metabolized in the kidneys to shorter peptides and aminoacids.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Netherlands
Trasylol · Trasylol, oplossing voor infusie 10.000 KIE/mlBelgium
Trasylol · Trasylol sol. inj. i.v. flac.United Kingdom
Aprotinin · Aprotinin 15,000 Kallikrein inactivator units/5ml irrigation solution vials · Aprotinin 15,000 Kallikrein inactivator units/5ml solution vials · Aprotinin 3,000 Kallikrein inactivator units/1ml irrigation solution vials · Aprotinin 3,000 Kallikrein inactivator units/1ml solution vials · Aprotinin 500,000 Kallikrein inactivator units/50ml solution for infusion vials · Aprotinin 6,000 Kallikrein inactivator units/2ml irrigation solution vials · Aprotinin 6,000 Kallikrein inactivator units/2ml solution vials · Trasylol · Trasylol 1,000,000 Kallikrein inactivator units/100ml solution for infusion vials · Trasylol 2,000,000 Kallikrein inactivator units/200ml solution for infusion vials · Trasylol 500,000 Kallikrein inactivator units/50ml solution for infusion vialsDenmark
TrasylolNorway
TrasylolPoland
TrasylolLuxembourg
TRASYLOLFinland
Trasylol
© NAPOS 2024